Tuesday, May 31, 2016

Jazz Pharma to buy Celator in $1.5B deal

Jazz Pharma will buy Celator Pharma, to gain access to an investigational product in development for treating acute myeloid leukemia.

from Mergers and Acquisitions http://ift.tt/1Vs3JUR

No comments:

Post a Comment